SeekingAlpha · Jul 20, 2026
BioGaia AB (publ) 2026 Q2 - Results - Earnings Call Presentation
2026-07-20. The following slide deck was published by BioGaia AB (publ) in conjunction with their 2026 Q2 earnings call.

OTC · BIOGY
Healthcare · Drug Manufacturers - Specialty & Generic
$12.45
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 9:14 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
BIOGY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning BIOGY.
BIOGY research
Company profile and research snapshot.
BIOGAIA AB S/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 5, 2026 | DNB CARNEGIE | Buy | — |
| Jun 17, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
| Feb 16, 2026 | DNB CARNEGIE | Buy | — |
| Feb 13, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
| Jan 14, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Jul 20, 2026
2026-07-20. The following slide deck was published by BioGaia AB (publ) in conjunction with their 2026 Q2 earnings call.
SeekingAlpha · Jul 17, 2026
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call July 17, 2026 3:30 AM EDTCompany ParticipantsTheresa Agnew - CEO & PresidentAlexander Kotsinas -...
SeekingAlpha · Jun 2, 2026
SeekingAlpha · Feb 18, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BIOGY.
No results
No recent SID articles mention BIOGY.